Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS GLENMARK PHARMA J.B.CHEMICALS/
GLENMARK PHARMA
 
P/E (TTM) x 37.7 12.3 307.0% View Chart
P/BV x 6.8 1.6 432.4% View Chart
Dividend Yield % 0.9 0.6 142.1%  

Financials

 J.B.CHEMICALS   GLENMARK PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-22
GLENMARK PHARMA
Mar-21
J.B.CHEMICALS/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,985573 346.6%   
Low Rs1,206195 617.7%   
Sales per share (Unadj.) Rs313.7387.8 80.9%  
Earnings per share (Unadj.) Rs50.034.4 145.3%  
Cash flow per share (Unadj.) Rs59.450.1 118.5%  
Dividends per share (Unadj.) Rs16.502.50 660.0%  
Avg Dividend yield %1.00.7 158.8%  
Book value per share (Unadj.) Rs268.0249.6 107.4%  
Shares outstanding (eoy) m77.28282.17 27.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.11.0 513.7%   
Avg P/E ratio x31.911.2 286.0%  
P/CF ratio (eoy) x26.97.7 350.7%  
Price / Book Value ratio x6.01.5 386.9%  
Dividend payout %33.07.3 454.2%   
Avg Mkt Cap Rs m123,307108,353 113.8%   
No. of employees `000NANA-   
Total wages/salary Rs m4,39223,437 18.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m24,242109,439 22.2%  
Other income Rs m401502 79.8%   
Total revenues Rs m24,643109,941 22.4%   
Gross profit Rs m5,42621,289 25.5%  
Depreciation Rs m7274,436 16.4%   
Interest Rs m513,531 1.5%   
Profit before tax Rs m5,04913,825 36.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,1894,124 28.8%   
Profit after tax Rs m3,8609,701 39.8%  
Gross profit margin %22.419.5 115.1%  
Effective tax rate %23.529.8 78.9%   
Net profit margin %15.98.9 179.6%  
BALANCE SHEET DATA
Current assets Rs m17,43073,596 23.7%   
Current liabilities Rs m8,51942,010 20.3%   
Net working cap to sales %36.828.9 127.4%  
Current ratio x2.01.8 116.8%  
Inventory Days Days57 69.1%  
Debtors Days Days83786 975.3%  
Net fixed assets Rs m13,26167,093 19.8%   
Share capital Rs m155282 54.8%   
"Free" reserves Rs m20,56070,148 29.3%   
Net worth Rs m20,71570,430 29.4%   
Long term debt Rs m038,888 0.0%   
Total assets Rs m30,691140,689 21.8%  
Interest coverage x99.64.9 2,026.3%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.8 101.5%   
Return on assets %12.79.4 135.5%  
Return on equity %18.613.8 135.3%  
Return on capital %24.615.9 155.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,94335,753 25.0%   
Fx outflow Rs m2,14312,023 17.8%   
Net fx Rs m6,80123,729 28.7%   
CASH FLOW
From Operations Rs m1,70111,312 15.0%  
From Investments Rs m23-6,752 -0.3%  
From Financial Activity Rs m-1,384-4,418 31.3%  
Net Cashflow Rs m341278 122.5%  

Share Holding

Indian Promoters % 0.0 46.7 -  
Foreign collaborators % 54.0 0.0 -  
Indian inst/Mut Fund % 26.7 34.7 76.7%  
FIIs % 8.9 24.2 36.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 46.0 53.4 86.2%  
Shareholders   60,268 312,473 19.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    AUROBINDO PHARMA    LUPIN    



Today's Market

Sensex Zooms 600 Points, Nifty Tops 17,700; IT and Banking Stocks Rally(10:30 am)

Asian share markets rose today after a slowdown in US inflation boosted hopes that the Federal Reserve will slow down its pace of interest rate hikes.